387 related articles for article (PubMed ID: 16962882)
1. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.
Pryor JL; Althof SE; Steidle C; Rosen RC; Hellstrom WJ; Shabsigh R; Miloslavsky M; Kell S;
Lancet; 2006 Sep; 368(9539):929-37. PubMed ID: 16962882
[TBL] [Abstract][Full Text] [Related]
2. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
[TBL] [Abstract][Full Text] [Related]
3. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.
McMahon CG; Althof SE; Kaufman JM; Buvat J; Levine SB; Aquilina JW; Tesfaye F; Rothman M; Rivas DA; Porst H
J Sex Med; 2011 Feb; 8(2):524-39. PubMed ID: 21059176
[TBL] [Abstract][Full Text] [Related]
5. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.
Buvat J; Tesfaye F; Rothman M; Rivas DA; Giuliano F
Eur Urol; 2009 Apr; 55(4):957-67. PubMed ID: 19195772
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
[TBL] [Abstract][Full Text] [Related]
7. Dapoxetine: in premature ejaculation.
Hoy SM; Scott LJ
Drugs; 2010 Jul; 70(11):1433-43. PubMed ID: 20614950
[TBL] [Abstract][Full Text] [Related]
8. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.
Kaufman JM; Rosen RC; Mudumbi RV; Tesfaye F; Hashmonay R; Rivas D
BJU Int; 2009 Mar; 103(5):651-8. PubMed ID: 19021601
[TBL] [Abstract][Full Text] [Related]
9. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials.
Porst H; McMahon CG; Althof SE; Sharlip I; Bull S; Aquilina JW; Tesfaye F; Rivas DA
J Sex Med; 2010 Jun; 7(6):2231-2242. PubMed ID: 20412423
[TBL] [Abstract][Full Text] [Related]
10. A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
Hutchinson K; Cruickshank K; Wylie K
Drug Saf; 2012 May; 35(5):359-72. PubMed ID: 22452563
[TBL] [Abstract][Full Text] [Related]
11. Dapoxetine for premature ejaculation: an updated meta-analysis of randomized controlled trials.
Li J; Yuan H; Bai Y; Pu C; Tang Y; Dong Q; Wei Q; Han P
Clin Ther; 2014 Dec; 36(12):2003-2014. PubMed ID: 25438723
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
Safarinejad MR
Clin Neuropharmacol; 2006; 29(5):243-52. PubMed ID: 16960468
[TBL] [Abstract][Full Text] [Related]
13. Dapoxetine for premature ejaculation.
McMahon CG
Expert Opin Pharmacother; 2010 Jul; 11(10):1741-52. PubMed ID: 20540653
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation].
Yang L; Luo L; Chen XF; Fan JH; Liu RM; Wang XN; Nan XY; Zhang Y; Lin XF; Wang MZ; Xing JP; Yang ZS; Jian BL; He H; Wu DP; He DL
Zhonghua Nan Ke Xue; 2015 Oct; 21(10):892-5. PubMed ID: 26665676
[TBL] [Abstract][Full Text] [Related]
15. Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculation.
Althof SE; Brock GB; Rosen RC; Rowland DL; Aquilina JW; Rothman M; Tesfaye F; Bull S
J Sex Med; 2010 Jun; 7(6):2243-2252. PubMed ID: 20367770
[TBL] [Abstract][Full Text] [Related]
16. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation.
McMahon CG; Porst H
J Sex Med; 2011 Oct; 8(10):2707-25. PubMed ID: 21771283
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized clinical trials on intravaginal ejaculatory latency time, patient-reported outcomes, and adverse events.
Yue FG; Dong L; Hu TT; Qu XY
Urology; 2015 Apr; 85(4):856-61. PubMed ID: 25817107
[TBL] [Abstract][Full Text] [Related]
18. Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized controlled trials with trial sequential analysis.
Li J; Liu D; Wu J; Fan X; Dong Q
Ann Saudi Med; 2018; 38(5):366-375. PubMed ID: 30284992
[TBL] [Abstract][Full Text] [Related]
19. [Dapoxetine for premature ejaculation: Advances in clinical studies].
Zhou TY; Li YF
Zhonghua Nan Ke Xue; 2015 Oct; 21(10):931-6. PubMed ID: 26665685
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review.
Russo A; Capogrosso P; Ventimiglia E; La Croce G; Boeri L; Montorsi F; Salonia A
Int J Clin Pract; 2016 Sep; 70(9):723-33. PubMed ID: 27456527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
